Selected article for: "cell carcinoma and high expression"
Author: Wang, Yao; Gao, Ying; Chen, Hai-Ruo; Liu, Hong; Fu, Xi; Yan, Ran; You, Feng-Ming; Li, Zhuo-Hong
Title: Primary Pleural Squamous Cell Carcinoma, Highly Positive PD-L1, Shows Marked Response to Camrelizumab: A Case Report
  • Cord-id: 9x9prihu
  • Document date: 2021_7_12
    • ID: 9x9prihu
    Snippet: Here, we reported the rare case of primary pleural squamous cell carcinoma (PPSCC) in a 71-year-old male patient. After chemo and targeted therapies, the patient showed continuous tumor progression and clinical deterioration. Fortunately, the patient had a high expression level of PD-L1 (80%) in the tumor tissues. Ultimately, the patient survived for additional 6 months with camrelizumab treatment. In summary, camrelizumab may be a good candidate for the treatment of PPSCC, especially in tumors
    Document: Here, we reported the rare case of primary pleural squamous cell carcinoma (PPSCC) in a 71-year-old male patient. After chemo and targeted therapies, the patient showed continuous tumor progression and clinical deterioration. Fortunately, the patient had a high expression level of PD-L1 (80%) in the tumor tissues. Ultimately, the patient survived for additional 6 months with camrelizumab treatment. In summary, camrelizumab may be a good candidate for the treatment of PPSCC, especially in tumors with high PD-L1 expression.

    Search related documents:
    Co phrase search for related documents
    • acid testing and admission test: 1
    • acid testing and admission time: 1, 2, 3, 4, 5
    • acid testing and lung infection: 1, 2, 3, 4
    • acid testing and magnetic resonance: 1
    • active treatment and admission time: 1, 2
    • active treatment and lung infection: 1, 2, 3, 4, 5
    • active treatment and lymph node: 1
    • active treatment and magnetic resonance: 1, 2, 3, 4, 5